Profile
Dr. Hella Kohlhof is a Chief Scientific Officer at Immunic, Inc. Dr. Kohlhof was previously employed as a Chief Science Officer by Vital Therapies, Inc., a Director-Projects Development by 4SC AG, and a Managing Director by Immunic Research GmbH.
She received her doctorate degree from Ludwig-Maximilians-Universität München.
Hella Kohlhof active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNIC, INC. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Former positions of Hella Kohlhof
| Companies | Position | End |
|---|---|---|
Immunic Research GmbH | Chief Executive Officer | - |
| 4SC AG | Corporate Officer/Principal | - |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Chief Tech/Sci/R&D Officer | - |
Training of Hella Kohlhof
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Immunic Research GmbH |
- Stock Market
- Insiders
- Hella Kohlhof
















